Skip to results
Modify your search
NARROW
1-7 of 7
Authors: Apostolia M. Tsimberidou
Sort by
Journal Article
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul and others
The Oncologist, Volume 29, Issue 4, April 2024, Pages e514–e525, https://doi.org/10.1093/oncolo/oyad338
Published: 31 January 2024
Journal Article
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson and others
The Oncologist, Volume 28, Issue 12, December 2023, Pages 1100–e1292, https://doi.org/10.1093/oncolo/oyad158
Published: 13 June 2023
Journal Article
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials
Ryan W. Huey and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 588–596, https://doi.org/10.1002/onco.13767
Published: 21 April 2021
Journal Article
Overview of Ocular Side Effects of Selinexor
Nagham Al-Zubidi and others
The Oncologist, Volume 26, Issue 7, July 2021, Pages 619–623, https://doi.org/10.1002/onco.13756
Published: 08 April 2021
Journal Article
Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience
Hazem El‐Osta and others
The Oncologist, Volume 16, Issue 9, September 2011, Pages 1292–1298, https://doi.org/10.1634/theoncologist.2011-0043
Published: 22 August 2011
Journal Article
Cardiovascular Toxicity Profiles of Vascular‐Disrupting Agents
Ishwaria M. Subbiah and others
The Oncologist, Volume 16, Issue 8, August 2011, Pages 1120–1130, https://doi.org/10.1634/theoncologist.2010-0432
Published: 08 July 2011
Journal Article
Outcomes of Patients with Advanced Non‐Small Cell Lung Cancer Treated in a Phase I Clinic
Filip Janku and others
The Oncologist, Volume 16, Issue 3, March 2011, Pages 327–335, https://doi.org/10.1634/theoncologist.2010-0308
Published: 21 February 2011
Advertisement
Advertisement